HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation.

Abstract
The objective of this study was to determine whether administration of a catalytic antioxidant, Mn(III) tetrakis(N,N'-diethylimidazolium-2-yl) porphyrin, AEOL10150, reduces the severity of long-term lung injury induced by fractionated radiation (RT). Fisher 344 rats were randomized into five groups: RT+AEOL10150 (2.5 mg/kg BID), AEOL10150 (2.5 mg/kg BID) alone, RT+ AEOL10150 (5 mg/kg BID), AEOL10150 (5 mg/kg BID) alone and RT alone. Animals received five 8 Gy fractions of RT to the right hemithorax. AEOL10150 was administered 15 min before RT and 8 h later during the period of RT treatment (5 days), followed by subcutaneous injections for 30 days, twice daily. Lung histology at 26 weeks revealed a significant decrease in lung structural damage and collagen deposition in RT+AEOL10150 (5 mg/kg BID) group, in comparison to RT alone. Immunohistochemistry studies revealed a significant reduction in tissue hypoxia (HIF1alpha, CAIX), angiogenic response (VEGF, CD-31), inflammation (ED-1), oxidative stress (8-OHdG, 3-nitrotyrosine) and fibrosis pathway (TGFbeta1, Smad3, p-Smad2/3), in animals receiving RT+ AEOL10150 (5 mg/kg BID). Administration of AEOL10150 at 5 mg/kg BID during and after RT results in a significant protective effect from long-term RT-induced lung injury. Low dose (2.5 mg/kg BID) delivery of AEOL10150 has no beneficial radioprotective effects.
AuthorsZahid N Rabbani, Fawzia K Salahuddin, Pavel Yarmolenko, Ines Batinic-Haberle, Bradley A Thrasher, Benjamin Gauter-Fleckenstein, Mark W Dewhirst, Mitchell S Anscher, Zeljko Vujaskovic
JournalFree radical research (Free Radic Res) Vol. 41 Issue 11 Pg. 1273-82 (Nov 2007) ISSN: 1071-5762 [Print] England
PMID17957541 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • AEOL 10150
  • Antioxidants
  • Metalloporphyrins
Topics
  • Animals
  • Antioxidants (administration & dosage, pharmacology)
  • Catalysis
  • Cytoprotection (drug effects)
  • Dose Fractionation, Radiation
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Female
  • Lung (drug effects, radiation effects)
  • Lung Diseases (etiology, prevention & control)
  • Metalloporphyrins (administration & dosage, pharmacology)
  • Models, Biological
  • Molecular Weight
  • Radiation Injuries, Experimental (prevention & control)
  • Random Allocation
  • Rats
  • Rats, Inbred F344

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: